Snibe board proposes CNY1021m dividend, green policies highlighted

** Shenzhen New Industries Biomedical Engineering (SZSE: 300832) has released its 2024 annual report and related announcements, proposing a CNY 1021 million dividend payout and outlining a strong commitment to Environment, Social, and Governance (ESG) principles. The board proposes a cash dividend of CNY 1.3 per share, subject to shareholder approval on May 19th. As part of its ESG commitments, the company highlighted its adoption of green manufacturing technologies, waste and emissions management, responsible supply chain practices (95.90% of suppliers are from Chinese mainland), and investments in renewable energy and water conservation. Additionally, the company is actively involved in R&D with investment reaching CNY 453.59 million. The company emphasizes talent development and community contribution and is committed to improving the well-being of staff and providing customer-centric services. The company's detailed 2024 ESG report is available on its website. The board has also scheduled its Annual General Meeting (AGM) for May 19th to vote on the dividend and other matters.